Skip to main content

Table 4 Outcomes and survival analysis

From: Liver resection of hepatocellular carcinoma in HIV-HCV co-infected patients: a retrospective case series

 

HIV+/HCV+

HIV−/HCV−

p-value

Days of hospitalization

°Mean ± SD

9.6 ± 4.45

10.81 ± 3.71

0.6

Complications, n (%)

2 (40)

8 (72.72)

0.299

Clavien-Dindo score, mean ± SD

1 ± 1.41

1.36 ± 1.2

0.594

°< 2

4 (80)

10 (90.91)

0.99

°> 2

1 (20)

1 (9.09)

Comprehensive complication index

°Mean ± SD (min; max)

12.8 ± 17.6 (0; 34)

12.7 ± 11.2 (0; 34)

0.815

°Median (25; 75° percentile)

0 (0; 30)

9 (4.5; 21.5)

 

Postoperative ascites, n (%)

0

2 (18.18)

0.99

Overall survival (months)

°Mean ± SE

36 ± 2.59

29.9 ± 3.49

0.443

°Death, n (%)

1 (20)

4 (36.36)

0.99

°OS at 1 year

100%

90%

 

°OS at 3 years

75%

53.3%

 

Recurrence-free survival (months)

°Mean ± SE

27 ± 5.69

26.78 ± 4.41

0.873

°Relapse, n (%)

2 (40)

4 (36.36)

1

°RFS at 1 year

80%

80.8%

 

°RFS at 3 years

53.3%

58.9%

 

Type of relapse, n (%)

°Extrahepatic, n (%)

0

0

 

°Intrahepatic, n (%)

2

4

 

°Local recurrence, n (%)

0

2 (50)

0.467

°Distant intrahepatic, n (%)

2 (100)

2 (50)

Treatment of relapse, n (%)

°Liver resection

0

0

 

°Termoablation

0

1 (25)

 

°Liver transplant

1 (50)

0

 

°TACE

0

0

0.20

°Medical treatment

0

3 (75)

 

°Palliative treatment

1 (50)

0

 

°Other

0

0

 
  1. SD standard deviation, SE standard error